News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Shah Nimish P
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/17/2023 |
4
| Shah Nimish P (Director) has filed a Form 4 on Apogee Therapeutics, Inc.
Txns:
| Bought 1,750,000 shares
@ $17, valued at
$29.8M
Granted 47,758 options to buy
@ $17, valued at
$811.9k
|
|
07/13/2023 |
3
| Shah Nimish P (Director) has filed a Form 3 on Apogee Therapeutics, Inc. |
10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/17/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.
Txns:
| Bought 4,674 shares
@ $11.98, valued at
$56k
Bought 170,292 shares
@ $11.67, valued at
$2M
|
|
10/11/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.
Txns:
| Bought 28,900 shares
@ $12, valued at
$346.8k
Bought 80,314 shares
@ $11.89, valued at
$954.9k
Bought 25,000 shares
@ $11.85, valued at
$296.3k
|
|
10/06/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.
Txns:
| Bought 223,100 shares
@ $11.81, valued at
$2.6M
|
|
10/03/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.
Txns:
| Bought 168,187 shares
@ $9.92, valued at
$1.7M
Bought 268,736 shares
@ $11.27, valued at
$3M
|
|
09/28/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.
Txns:
| Bought 395,614 shares
@ $8.56, valued at
$3.4M
Bought 115,000 shares
@ $9.38, valued at
$1.1M
Bought 76,600 shares
@ $9.92, valued at
$759.9k
|
|
09/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/25/2021 |
4
| Shah Nimish P (Director) has filed a Form 4 on Instil Bio, Inc.
Txns:
| Converted 5,100,866 shares
@ $0 Converted 510,030 shares
@ $0 Converted 430,431 shares
@ $0 Converted 43,033 shares
@ $0 Converted 480,716 shares
@ $0 Bought 104,640 shares
@ $20, valued at
$2.1M
Bought 10,470 shares
@ $20, valued at
$209.4k
Bought 116,880 shares
@ $20, valued at
$2.3M
Bought 48,390 shares
@ $20, valued at
$967.8k
Bought 19,620 shares
@ $20, valued at
$392.4k
Converted 4,250,722 preferred shares
@ $0 |
|
03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/22/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
03/18/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/01/2021 |
4
| Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on Altimmune, Inc.
Txns:
| Disposed of 1,000,000 shares
@ $0 Acquired 1,000,000 warrants
@ $0.0001, valued at
$100 |
|
08/18/2020 |
4
| Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on Unum Therapeutics Inc.
Txns:
| Bought 100,000 shares
@ $2.3, valued at
$230k
Bought 250,000 shares
@ $2.57, valued at
$642.5k
Bought 101,000 shares
@ $2.62, valued at
$264.6k
|
|
08/18/2020 |
3
| Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 3 on Unum Therapeutics Inc. |
06/15/2020 |
4
| Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on Altimmune, Inc.
Txns:
| Bought 1,500,000 shares
@ $7.54, valued at
$11.3M
|
|
05/28/2020 |
4
| Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on Altimmune, Inc.
Txns:
| Bought 309,453 shares
@ $8.79, valued at
$2.7M
Bought 390,547 shares
@ $9.78, valued at
$3.8M
Bought 125,162 shares
@ $7.23, valued at
$904.9k
Bought 277,000 shares
@ $7.92, valued at
$2.2M
Bought 27,763 shares
@ $7.79, valued at
$216.3k
Bought 173,711 shares
@ $8.87, valued at
$1.5M
|
|
|
|
|